跳到正文
HSA 治疗药品召回·· 7 天前精选AI 评分61

新加坡HSA召回Farganesse Injection 50mg/2ml(异丙嗪)4个批次,因安瓿中出现颗粒物

Recall of Farganesse Injection 50mg/2ml (promethazine)

AI 导读

新加坡HSA于2026年11月12日召回Farganesse Injection 50mg/2ml(异丙嗪),问题为安瓿中存在颗粒物。召回级别为1级,范围为零售环节,涉及批次0015318、0015319、0015320、0015321,本地公司为FarmaMondo Pte. Ltd.与Pharm-D (Singapore) Pte. Ltd.。

推荐理由

材料给出1级召回涉及的四个批次与零售环节停用、退库要求,可对照手头库存批号核实是否在范围内。

正文 · 原文

Date of recall:

12 November 2026

Product:

Farganesse Injection 50mg/2ml

Active Ingredient:

Promethazine

Product Category:

Therapeutic Product

Batch No.:

0015318, 0015319, 0015320, 0015321

Class of Recall:

1

Level of Recall:

Retail

Local Company:

FarmaMondo Pte. Ltd.

Pharm-D (Singapore) Pte. Ltd.

Description of Issue:

Presence of particles in ampoules.

Recall Instructions:

Hospitals, clinics, pharmacies:

Stop supplying the affected batch and return the remaining stocks to the company.

来源:HSA 治疗药品召回 · hsa.gov.sg